Ainos (OTCMKTS:AIMD) Stock Price Down 8.7% – Here’s Why

Ainos, Inc. (OTCMKTS:AIMD)’s stock price was down 8.7% during trading on Friday . The stock traded as low as $0.47 and last traded at $0.49. Approximately 145,917 shares changed hands during mid-day trading, a decline of 86% from the average daily volume of 1,074,453 shares. The stock had previously closed at $0.54.

Ainos Stock Performance

The company’s 50 day moving average price is $0.58 and its 200-day moving average price is $0.84. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.45 and a current ratio of 1.92. The company has a market cap of $3.21 million, a PE ratio of -0.19 and a beta of 1.40.

Ainos (OTCMKTS:AIMD) last released its quarterly earnings data on Monday, August 5th. The company reported ($0.49) EPS for the quarter. Ainos had a negative return on equity of 44.32% and a negative net margin of 515.80%.

Ainos Company Profile

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.